HM Approved MHRA Licence Holder
March 2, 201819th Annual Clinical Trial Supply Europe 2018
March 9, 2018
Hennessy Mason will be heading to Porto to attend the 2nd Biotech Pharma Summit: Biosimilars & Biologics 2018.
Over 20 presentations will be made by industry leaders, focussing on market access strategies, clinical development, commercialisation, manufacturing and bio-analytics.
Hennessy Mason is excited to attend this leading event to engage with biosimilar and innovator pharmaceutical manufacturers, payers and providers to showcase its global network and innovative approach in this dynamic market.
